A meta-analysis of 2 well randomized trials using ciliary neurotrophic factor (CNTF) as a DMT in 1300 MND patients showed no significant difference between it and placebo, unlike findings reported in animal models which were favorable [35]. This evidence concerns the gene CNTF and mild neurocognitive disorder.